186 related articles for article (PubMed ID: 2658822)
1. [Studies of second-look operations (SLO) in ovarian cancer].
Yuzawa H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
[TBL] [Abstract][Full Text] [Related]
2. [Reassessment of second-look operations (SLO) in the treatment of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1303-9. PubMed ID: 2730043
[TBL] [Abstract][Full Text] [Related]
3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
4. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
5. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer].
Ohta M; Tomoda Y; Kano T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004
[TBL] [Abstract][Full Text] [Related]
6. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prognostic factors of epithelial ovarian cancer].
Wei L; Qian H; Li W
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):476-9. PubMed ID: 9639741
[TBL] [Abstract][Full Text] [Related]
8. [Significance of second look surgery in the therapy of ovarian cancer].
Sasaki H; Ochiai K; Terashima Y
Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
12. The current therapeutic approaches to advanced ovarian cancer.
Nishimura H; Hamaguchi K; Miyahara K; Tazaki T; Tateno N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1691-6. PubMed ID: 2277209
[TBL] [Abstract][Full Text] [Related]
13. [Long-term clinical course after second laparotomy in ovarian cancer].
Stöckle E; Chauvergne J; Pigneux J; Avril A; Bussières E; Thomas L; Chevalier M; Marée D
Bull Cancer; 1990; 77(11):1087-98. PubMed ID: 2275986
[TBL] [Abstract][Full Text] [Related]
14. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
15. Stage III-IV epithelial carcinoma of the ovary: is the second-look operation of any value for the patient?
Atad J; Bornstein J; Steiner M; Weill S; Lurie M; Abramovici H
Isr J Med Sci; 1988 Nov; 24(11):660-3. PubMed ID: 3215758
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategy in the management of stage II-IV epithelial ovarian carcinoma.
Sun T; Feng Y; Zhu Y; Zheng Y
Chin Med J (Engl); 2000 Jul; 113(7):625-7. PubMed ID: 11776033
[TBL] [Abstract][Full Text] [Related]
17. [Recurrent epithelial ovarian cancer].
Ding X; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):30-2. PubMed ID: 11263170
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of second cytoreductive surgery in the treatment of epithelial ovarian cancer.
Sun T; Feng Y
Chin Med J (Engl); 1998 Mar; 111(3):272-4. PubMed ID: 10374433
[TBL] [Abstract][Full Text] [Related]
19. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer].
Li M; Huang X
Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy and surgical procedure in the management of ovarian malignancies. Evaluation of second look operations].
Yakushiji M; Nishimura H
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1664-70. PubMed ID: 3592708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]